However, both compounds individually cause: Nausea (60-80% of users at higher doses) Vomiting (20-35%) Diarrhea (25-40%) Injection site reactions (15-25%) Potential pancreatitis (rare but serious) Combining these compounds could theoretically amplify these effects, though the actual incidence and severity remain unstudied
Zhang and Cheng, 2022) (Table 1)
Molecular docking experiments were conducted with four target proteins (COX-2, MMP-9, TNF-, and MPO) to explore the interaction between mesalamine (compound 36, Figure 26) and its coumarin derivative, MS-CU
USA 116 , 88598868 (2019)
A search on PubMed returns many papers on rodents and cell models, and reviews on PubMed Central describe it as a possible therapy rather than a proven one
The trans-3-hexenoic acid modification improves resistance to dipeptidyl peptidase IV (DPP-IV) cleavage compared to native GHRH, but reconstituted peptide should still be handled carefully to preserve biological activity